Three USC researchers win $4.3 million in awards from California’s stem cell agency

Three scientists from Keck Medicine of USC have won grants exceeding $4.3 million from the California Institute for Regenerative Medicine (CIRM) for research that includes creating a temporary liver for patients, finding novel ways to treat immune disorders and blood diseases, and developing new animal models for heart failure, diabetes and neurodegenerative diseases. The grants, …

Bell in the lab

Drug-like molecule points to novel strategies for cancer therapy

A decade ago, genome sequencing revealed a big surprise: about 50 percent of human cancers are linked to mutations in what are known as epigenetic regulators, which control the activity of genes. In a new study in Cell Chemical Biology, a team of scientists led by Oliver Bell from USC and Stephen V. Frye from …

Oliver Bell

Design redundancy is in our DNA

Design redundancy is not only an invention of engineers for building machines, but also a principle of nature for designing organisms. This principle is at play in the regulation of the genes responsible for directing stem cells to multiply themselves in the developing mouse embryo, as described in a new study in Science Advances.

Oliver Bell, PhD

Stay connected.